K-RAS Gene Mutations in Patients with Non-small Cell Lung Cancer

K-RAS Gene Mutations in Patients with Non-small Cell Lung Cancer

Background and objective Recent studies indicated that Non-small cell lung cancer (NSCLC) patients with mutant K-RAS failed to benefit from adjuvant chemotherapy, and the cancer did not respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). These findings indicated tha...

Full description

Bibliographic Details
Main Authors: Yang ZHANG, Zhenkui PAN, Xing ZHANG, Fei XU, Li ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2010-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
RAS gene
Mutation
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.06.007&path[]=1542

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.06.007&path[]=1542

Similar Items